We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 32 start-ups with an aggregate funding of $2.2b. The average funding per company in this subset is $67.7m.
Last update to the database: Feb 18, 2025. See changelog.
Arzeda is a biotechnology and software company designing custom microorganisms for industrial applications through computational enzyme design, protein optimization, and metabolic engineering.
5
Funding Rounds
$72.2m
Money raised
Molecular Assemblies, Inc. is an enzymatic DNA synthesis technology founded in 2013 by Curt Becker, Bill Efcavitch and William Efcavitch.
7
Funding Rounds
$83.0m
Money raised
Metabolon is a company developing metabolomics analytical methods and software for biomarker discovery
5
Funding Rounds
$57.1m
Money raised
DNA synthesis company using enzymatic DNA synthesis based in San Francisco.
4
Funding Rounds
$87.8m
Money raised
Genapsys is a company developing DNA sequencing technologies and systems founded in 2010 by Hesaam Esfandyarpour.
10
Funding Rounds
$402.1m
Money raised
TFF Pharmaceuticals is a dry-powder Inhalation for Respiratory Therapies founded in 2018.
2
Funding Rounds
$22.2m
Money raised
Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.
3
Funding Rounds
$50.6m
Money raised
Crown bioscience is a company that is focused on research, drug discovery and development for the treatment of cancer and diabetes.
6
Funding Rounds
$62.1m
Money raised
A non-profit organization with a focus on scientific and engineering research. It was founded in 1941 and is located in Birmingham, Alabama.
2
Funding Rounds
$8.7m
Money raised
Biocrates Life Sciences AG is an Innsbruck-based medical diagnostics company focused on metabolomic research and technology.
8
Funding Rounds
$13.6m
Money raised
ReviveMed is a biotech start-up that analyses metabolomic data using artificial intelligence, which allows them to design new medical therapeutics.
2
Funding Rounds
$1.5m
Money raised
Manus Biosynthesis is a synthetic biology company producing ingredients through fermentation founded in 2011 by Ajikumar Parayil.
2
Funding Rounds
$94.4m
Money raised
Almac is a biomedical services company based in the UK founded in 1968 by Allen McClay.
2
Funding Rounds
$1.4m
Money raised
A company that provides services and technologies for the development and commercialization of biopharmaceutical products
2
Funding Rounds
$20.0m
Money raised
Nimbus Therapeutics is a Computer-Based Drug Discovery founded in 2011 by Bruce Booth.
4
Funding Rounds
$53.0m
Money raised
Sygnature Discovery Limited is a drug Discovery Contract Research founded in 2004 by Simon Hirst.
1
Funding Rounds
A company that develops selective medicines for the treatment of cancer
1
Funding Rounds
$33.0m
Money raised
Lyndra Therapeutics is a drug Delivery founded in 2015.
3
Funding Rounds
$143.0m
Money raised
Encodia Inc. is a protein Analysis Technologies founded in 2015.
1
Funding Rounds
$75.0m
Money raised
Cirius Therapeutics is a company developing an insulin sensitizer for the treatment of non-alcoholic steatohepatitis.
1
Funding Rounds
$40.0m
Money raised
Apostle Inc is a Sunnyvale, California-based company providing technologies and services for public health and life sciences.
2
Funding Rounds
$5.7m
Money raised
Element Biosciences is a genetic analysis tools.
2
Funding Rounds
$291.0m
Money raised
Sagimet Biosciences Inc. is a drugs targeting the fatty acid synthase enzyme.
3
Funding Rounds
$185.0m
Money raised
SFA Therapeutics is a microbiome-derived metabolites as drugs founded in 2016 by Ira Spector, Mark Feitelson and Alla Arzumanyan.
1
Funding Rounds
$4.0m
Money raised
BioHybrid Solutions is a company founded by Krzysztof Matyjaszewski, Alan Russell and Antonina Simakova.
1
Funding Rounds
Poxel is a biopharmaceutical company developing drugs for metabolic diseases founded in 2009.
1
Funding Rounds
$20.3m
Money raised
Debut Biotechnology is a Cell-Free Biomanufacturing.
2
Funding Rounds
$25.2m
Money raised
reMYND is a preclinical In-Vivo Alzheimer's Contract Research.
1
Funding Rounds
$14.5m
Money raised
Developer of therapeutics for chronic autoimmune and inflammatory diseases.
2
Funding Rounds
$80.0m
Money raised
EdenRoc Sciences LLC is a Cambridge, Massachusetts-based company founded in 2016.
7
Funding Rounds
$139.0m
Money raised
Azafaros is a small Molecules.
1
Funding Rounds
$27.5m
Money raised
Adlai Nortye Biopharma is a China-based company.
1
Funding Rounds
$53.0m
Money raised